Azupharma

Azupharma was a leading German pharmaceutical company that specialized in the development, production, and marketing of generic medicines. Based in Gerlingen, Germany, the company established a strong presence in the domestic market with a broad portfolio of off-patent drugs covering therapeutic areas such as cardiovascular health, metabolic disorders, and infectious diseases. In 2003, as part of a strategic initiative by its parent company Novartis to consolidate its global generics business, Azupharma was rebranded and integrated into the Sandoz division. Today, the company's extensive range of affordable medications continues to be distributed under the Sandoz brand, maintaining its legacy as a key provider of essential healthcare solutions in Europe. The company was known for its "Azu" prefix on many of its products, which became a trusted name for pharmacists and patients across Germany.